$HON

Honeywell (NASDAQ: HON) Q2 2026 profit surges on Quantinuum gain

Honeywell (HON) amended its Q2 2026 report to correct segment backlog presentation. It said Q2 and YTD 2026 net sales rose 4% and 3%. Profit was boosted by a $6,629 million gain from Quantinuum deconsolidation, while backlog rose 12% to $38,008 million. The filing also cites margin pressure, $311 million impairments, and a $241 million debt-extinguishment loss.

Original reporting
Published Jul 24, 2026, 10:02 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 3:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HON
Bullish
medium confidence
Mentioned
$HON · $QNT
Relevance
7/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$HONBullishMed
01

Why it matters

The filing highlights a large accounting gain from Quantinuum deconsolidation that lifts reported net income, while simultaneously showing weaker gross margin percentage, higher effective tax rate, and equity-method losses after Quantinuum became an equity-method investment.

02

Market read

This is a filing-driven earnings-quality update: reported profit is boosted by a large deconsolidation gain, but margin and tax effects are less favorable.

03

What to watch

Backlog growth (+12%) improves visibility, but cash declined and impairments on held-for-sale assets plus divestiture-related costs could pressure free cash flow and future earnings normalization.

Relevance 7/10Novelty 6/10Timing: today’s filing update for Q2 2026 results and backlog presentation

Background

Honeywell amended its Q2 2026 quarterly report to correct backlog presentation by business segment, alongside ongoing portfolio restructuring including an Aerospace spin-off and Quantinuum deconsolidation.

Company-level read

Ticker impact

$HONBullishMedium confidence
Context

Honeywell amended its Q2 2026 filing, reporting a $6,629 million gain from Quantinuum deconsolidation and updated segment backlog presentation.

Expected impact

Near-term sentiment likely positive on headline profit strength, but follow-through may be tempered by margin compression and higher effective tax rate.

Evidence & confidence

The article provides specific P&L drivers (deconsolidation gain, equity-method loss, tax rate jump, gross margin % decline) that can shift how traders value continuing-ops earnings versus one-time items.

Market effects

Aerospace and industrial automation peers may see read-across on portfolio reshaping and how deconsolidations affect reported earnings quality.

Limited direct regional impact; primarily US-listed industrial earnings optics.

Quantinuum-related accounting and spin-off mechanics can influence global investor perception of industrial quantum/tech partnerships and carve-out accounting.

Counterpoint

Traders may discount the deconsolidation gain as non-recurring and focus on continuing-ops margin percentage decline and higher effective tax rate.

Key entities

  • Honeywell International Inc.

    US industrial conglomerate filing amendment reporting Q2 2026 profit drivers and segment backlog correction.

  • Quantinuum

    Former Honeywell subsidiary that completed an IPO, triggering deconsolidation gain and subsequent equity-method accounting.

  • Aerospace Spin-Off

    Completed June 29, 2026 with a one-for-two reverse stock split, contributing divestiture-related costs and held-for-sale impairments.

  • Johnson Matthey Catalyst Technologies segment

    Honeywell acquired the segment for $1,750 million, adding to portfolio reshaping.

Related articles

$HONMed

Honeywell Aerospace Dives More Than 23%

Wall Street slipped as oil rose and more earnings were reported. The S&P 500 fell 0.2% to 7,709.96, the Dow fell 0.9% to 53,885.10, and the Nasdaq fell 0.1% to 26,348.35. Honeywell Aerospace dropped 23.2% after results missed forecasts, with CFO Josh Jepsen citing supply chain constraints. Brent rose 3.8% to $82.49 amid Iran Strait of Hormuz deal talks.

$HONHighAI 9/10

Honeywell Aerospace Q2 2026 earnings miss, cuts full-year outlook

Honeywell Aerospace reported Q2 2026 sales of $4.5B, up 5% YoY, and adjusted EBIT of $995M, down 7%, missing Wall Street expectations cited by Barron’s. Adjusted EPS was $1.87. The company cut full-year organic sales growth to 4% to 5% and adjusted EBIT to $4.35B–$4.45B, citing supply chain constraints. Backlog rose to $18.2B.

$HONHighAI 9/10

Honeywell Aerospace Shares Plunge 20% as Newly Spun-Off Company Slashes 2026 Sales Outlook on Its First Report

Honeywell Aerospace shares fell about 20% to $163 after its first standalone quarterly report cut 2026 guidance. The company reported Q2 organic sales of $4.5B and adjusted EPS of $1.78, but lowered full-year organic sales growth to 4% to 5% and adjusted EPS to $7.60 to $7.90, citing supply chain constraints. It plans to add 50+ suppliers and raise supplier tooling spending.

$HONMedAI 8/10

Honeywell Aerospace Cuts 2026 Outlook As Supply Snags Bite

Honeywell Aerospace said supply constraints are hurting results and cut its 2026 outlook. The company cited a shift toward US defense and space work, higher spending on multi-sourcing and in-sourcing, and about $100 million in separation and inventory charges. In the latest quarter, adjusted EPS fell 32% while sales rose 5% to $4.52 billion, and it guided 2026 EPS of $7.60 to $7.90.

$HONMed

HON Stock Jumps After Its Quantum Computing Subsidiary Files For IPO

Honeywell International (HON) shares rose about 2% after-hours after its quantum computing subsidiary Quantinuum filed a U.S. IPO registration statement with the SEC. Honeywell holds about 54%. JPMorgan Chase and Morgan Stanley lead the offering. Quantinuum reported a net loss of $136.6 million on $5.2 million revenue for the quarter ended March 31.